205 related articles for article (PubMed ID: 34352355)
1. The antithrombotic activity of natural and synthetic coumarins.
Gao L; Wang F; Chen Y; Li F; Han B; Liu D
Fitoterapia; 2021 Oct; 154():104947. PubMed ID: 34352355
[TBL] [Abstract][Full Text] [Related]
2. Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives.
Kontogiorgis C; Nicolotti O; Mangiatordi GF; Tognolini M; Karalaki F; Giorgio C; Patsilinakos A; Carotti A; Hadjipavlou-Litina D; Barocelli E
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):925-33. PubMed ID: 25807297
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies for multitarget antithrombotic drugs.
Neves AR; Correia-da-Silva M; Sousa E; Pinto M
Future Med Chem; 2016 Dec; 8(18):2305-2355. PubMed ID: 27845573
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential.
Hoult JR; Payá M
Gen Pharmacol; 1996 Jun; 27(4):713-22. PubMed ID: 8853310
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 3-carboxamide-benzocoumarin derivatives as orally active antithrombotic agents.
Sashidhara KV; Kumar A; Kumar M; Singh S; Jain M; Dikshit M
Bioorg Med Chem Lett; 2011 Dec; 21(23):7034-40. PubMed ID: 22004722
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
[TBL] [Abstract][Full Text] [Related]
8. A biological, fluorescence and computational examination of synthetic coumarin derivatives with antithrombotic potential.
Kasperkiewicz K; Ponczek MB; Budzisz E
Pharmacol Rep; 2018 Dec; 70(6):1057-1064. PubMed ID: 30296741
[TBL] [Abstract][Full Text] [Related]
9. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
Keri RS; Budagumpi S; Balappa Somappa S
J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel, potent, isosteviol-based antithrombotic agents.
Chen P; Zhang D; Li M; Wu Q; Lam YPY; Guo Y; Chen C; Bai N; Malhotra S; Li W; O'Connor PB; Fu H
Eur J Med Chem; 2019 Dec; 183():111722. PubMed ID: 31563807
[TBL] [Abstract][Full Text] [Related]
11. Clinically important drug interactions with anticoagulants. An update.
Harder S; Thürmann P
Clin Pharmacokinet; 1996 Jun; 30(6):416-44. PubMed ID: 8792056
[TBL] [Abstract][Full Text] [Related]
12. A Review on Anti-urease Potential of Coumarins.
Asghar H; Asghar H; Asghar T
Curr Drug Targets; 2021; 22(17):1926-1943. PubMed ID: 33618646
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors.
Bouckaert C; Serra S; Rondelet G; Dolušić E; Wouters J; Dogné JM; Frédérick R; Pochet L
Eur J Med Chem; 2016 Mar; 110():181-94. PubMed ID: 26827162
[TBL] [Abstract][Full Text] [Related]
14. Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents.
Jameel E; Umar T; Kumar J; Hoda N
Chem Biol Drug Des; 2016 Jan; 87(1):21-38. PubMed ID: 26242562
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide.
Jain M; Surin WR; Misra A; Prakash P; Singh V; Khanna V; Kumar S; Siddiqui HH; Raj K; Barthwal MK; Dikshit M
Chem Biol Drug Des; 2013 Apr; 81(4):499-508. PubMed ID: 23534412
[TBL] [Abstract][Full Text] [Related]
16. Current trends in antithrombotic drug and device development.
Fareed J
Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
[TBL] [Abstract][Full Text] [Related]
17. [Where to look for progress in antithrombotic treatments?].
Samama MM
Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
[TBL] [Abstract][Full Text] [Related]
18. Advances in antithrombotic agents.
Chakrabarti R; Das SK
Cardiovasc Hematol Agents Med Chem; 2007 Jul; 5(3):175-85. PubMed ID: 17630943
[TBL] [Abstract][Full Text] [Related]
19. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
20. New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: synthesis, in vivo antithrombotic evaluation and molecular docking.
Amin KM; Abdel Gawad NM; Abdel Rahman DE; El Ashry MK
Bioorg Chem; 2014 Feb; 52():31-43. PubMed ID: 24316885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
